The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Anh Nguyen

Anh Nguyen

0433 551 234 | anh.nguyen4@mh.org.au

Position:
Infectious Disease Modeler
Theme(s):
Viral Infectious Diseases
Unit(s):
Victorian Infectious Diseases Reference Laboratory (VIDRL), WHO Collaborating Centre for Viral Hepatitis
Lab Group(s):
Cowie Group

Anh Nguyen is an infectious disease modeller with current research aimed to develop disease burden estimation and mathematical modelling approaches to inform the surveillance, monitoring and evaluation of progress towards national strategies for the elimination of hepatitis B. Anh has a background in economics with a specialisation in health economics. He has held research positions in academia in Vietnam, working in health economics evaluation and HIV prevention. He’s currently in the final year of his PhD candidature at University of Tasmania, where he’s investigating the health economics aspects of Primary Liver Cancer.

Current professional memberships: 

  • The Professional Society for Health Economics and Outcomes Research
  • Australian Health Economics Society
  • Public Health Association of Australia
  • Publications
    Loading ORCID data…
    Projects
    • Blood-borne viruses and sexually transmissible infections surveillance and research program: surveillance for hepatitis B indicators

      A key aspect of Australia’s National Hepatitis B Strategy 2014-2017 is the identification of specific measurable aims and targets, including increasing the proportion of people living with chronic hepatitis B (CHB) who have been diagnosed, increasing treatment uptake in those affected, and reducing the burden of attributable morbidity and mortality associated with the disease.

      Learn more

    Research Groups
    • Cowie Group

      Ben’s group focuses on viral hepatitis epidemiological research. The team undertakes a broad range of activities supporting local, national and global control of viral hepatitis, through surveillance, treatment and prevention initiatives, and training and regional capacity building. 


      Lab Team

      Cowie Group